Miromatrix Medical Inc. Common Stock (MIRO)

MIRO was delisted on the 12th of December, 2023.

• Market cap: $93M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Miromatrix Medical Inc is a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives. Its pipeline products include; MiroliverELAP is External Liver Assist Product and is designed to provide liver dialysis for acute liver failure patients, Mirokidney is fully implantable bioengineered kidney intended to treat patients with end-stage renal disease, Miroliver is fully implantable bioengineered liver intended to treat patients with acute and chronic liver failure, Miroheart, Mirolung, and Miropancreas.

Employees: 76